PharmPK Discussion - Preclinical interaction data with tPA for drug development in acute stroke

PharmPK Discussion List Archive Index page

On 21 Feb 2005 at 09:30:15, Martin.W.Lunnon.at.gsk.com sent the message


I would be interested in any details of preclinical interaction studies
with tPA required by Regulatory agences with respect to developing an
NCE in acute stroke,

thanks,

Martin W Lunnon

GlaxoSmithKline R&D
Neurology CEDD Harlow
tel 01279 875164
fax 01279 875246
e-mail: Martin_W_Lunnon.at.gsk.com

Back to the Top

Want to post a follow-up message on this topic? If this link does not work with your browser send a follow-up message to PharmPK@boomer.org with "Preclinical interaction data with tPA for drug development in acute stroke" as the subject

PharmPK Discussion List Archive Index page